+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rheumatoid Arthritis"

Rheumatoid Arthritis: Update Bulletin #3 - Product Thumbnail Image

Rheumatoid Arthritis: Update Bulletin #3

  • Newsletter
  • April 2024
  • Global
From
From
From
From
Autoimmune Disease Diagnosis Global Market Report 2024 - Product Thumbnail Image

Autoimmune Disease Diagnosis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Ankylosing Spondylitis Global Market Report 2024 - Product Thumbnail Image

Ankylosing Spondylitis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Alopecia Global Market Report 2024 - Product Thumbnail Image

Alopecia Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Autoimmune Disease Testing Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Autoimmune Disease Testing Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 148 Pages
  • Global
From
From
From
From
Loading Indicator

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other organs. It is a type of inflammatory arthritis that is caused by an overactive immune system. RA is a major cause of disability and is the most common form of inflammatory arthritis. It affects people of all ages, but is more common in women than men. Symptoms of RA include joint pain, swelling, stiffness, and decreased range of motion. Treatment for RA includes medications, physical therapy, and lifestyle changes. The RA market within the context of Allergy and Immunology is a rapidly growing market. It is driven by the increasing prevalence of RA, the development of new treatments, and the increasing demand for better treatments. The market is expected to grow due to the increasing awareness of RA and the increasing demand for better treatments. Some companies in the RA market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more